Skip to content
★ Sign in to follow
AP

Avi Pelossof

Executive
Neogen CorpAlere Inc.Chembio Diagnostics, Inc.
Total declarations
24
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 02 Oct 2026 for NEOGEN CORP, €106k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Avi Pelossof: trading record in brief

This profile gathers the share dealings of Avi Pelossof across 3 companies, led by Alere Inc., Chembio Diagnostics, Inc. and Neogen Corp. We count 24 filings; the first trade dates from 11 May 2006 and the latest from 1 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 2 October 2026: a share grant of €106k, in Neogen Corp. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Avi Pelossof

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total
  • ◆
    DirectorExecutivesNeogen Corp
    120,001 USD0SEC
    9,804 shares@ US$12.2450.6% of flowRestricted Stock UnitsSEC:0000711377-26-000025:0
  • ◆
    DirectorExecutivesNeogen Corp
    119,999 USD19SEC
    19,386 shares@ US$6.19100.0% of flowCommon StockSEC:0000711377-25-000058:0
  • ●
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    26,005 sharesCommon StockSEC:0000950142-17-001793:0
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    121,869 USD2SEC
    2,464 shares@ US$49.463.2% of flowCommon StockSEC:0001179110-17-012026:1
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    6,667 sharesCommon StockSEC:0001179110-17-012026:0
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    37,330 USD2SEC
    924 shares@ US$40.401.1% of flowCommon StockSEC:0001179110-17-002832:1
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    110,736 USD2SEC
    2,741 shares@ US$40.403.3% of flowCommon StockSEC:0001179110-17-002832:3
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    2,500 sharesCommon StockSEC:0001179110-17-002832:0
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    7,236 sharesCommon StockSEC:0001179110-17-002832:2
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    774,000 USD4SEC
    20,000 shares@ US$38.7023.1% of flowCommon StockSEC:0001179110-17-000380:0
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    776,217 USD4SEC
    19,903 shares@ US$39.0023.1% of flowCommon StockSEC:0001179110-17-000380:1
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    374,152 USD3SEC
    9,668 shares@ US$38.7011.2% of flowCommon StockSEC:0001179110-17-000380:2
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    375,068 USD3SEC
    9,627 shares@ US$38.9611.2% of flowCommon StockSEC:0001179110-17-000380:3
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    399,848 USD3SEC
    10,332 shares@ US$38.7011.9% of flowCommon StockSEC:0001179110-17-000380:4
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    399,846 USD3SEC
    10,263 shares@ US$38.9611.9% of flowCommon StockSEC:0001179110-17-000380:5
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    6,667 sharesCommon StockSEC:0001179110-16-029624:0
  • ◇
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    0SEC
    6,666 sharesCommon StockSEC:0001179110-15-012884:0
  • ◆
    GlobalPres, Infectious DiseaseExecutivesAlere Inc.
    128,054 USD0SEC
    2,464 shares@ US$51.97Common StockSEC:0001179110-15-012884:1
  • ◆
    VP Sales, Marketing & BDExecutivesChembio Diagnostics, Inc.
    15,500 USD0SEC
    25,000 shares@ US$0.62Common StockSEC:0001293462-07-000002:0
  • ◆
    VP Sales, Marketing & BDExecutivesChembio Diagnostics, Inc.
    60,000 USD0SEC
    100,000 shares@ US$0.60Common StockSEC:0001293462-06-000017:0
  • ●
    VP Sales, Marketing & B.D.ExecutivesChembio Diagnostics, Inc.
    0SEC
    290 sharesCommon StockSEC:0001293462-06-000016:0
  • ●
    Vice PresidentExecutivesChembio Diagnostics, Inc.
    0SEC
    403 sharesCommon StockSEC:0001293462-06-000010:1
  • ●
    Vice PresidentExecutivesChembio Diagnostics, Inc.
    0SEC
    106 sharesCommon StockSEC:0001293462-06-000010:0

23 of 23 declarations